These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30692685)

  • 21. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.
    Liu X; Yue C; Shi L; Liu G; Cao Q; Shan Q; Wang Y; Chen X; Li H; Wang J; Gao S; Niu M; Yu R
    J Cell Mol Med; 2020 Jul; 24(13):7550-7562. PubMed ID: 32452133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal lymphocyte homeostasis and function in MALT1 protease-resistant HOIL-1 knock-in mice.
    Skordos I; Driege Y; Haegman M; Kreike M; Staal J; Demeyer A; Beyaert R
    FEBS J; 2023 Apr; 290(8):2032-2048. PubMed ID: 36479846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression.
    Li Y; Huang S; Huang X; Li X; Falcon A; Soutar A; Bornancin F; Jiang Z; Xin HB; Fu M
    Cell Signal; 2018 Oct; 50():1-8. PubMed ID: 29913212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Function and targeting of MALT1 paracaspase in cancer.
    O'Neill TJ; Tofaute MJ; Krappmann D
    Cancer Treat Rev; 2023 Jun; 117():102568. PubMed ID: 37126937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Novel Fused Heteroaromatics-Based MALT1 Inhibitors by High-Throughput Screening to Treat B Cell Lymphoma.
    Liang X; Sun C; Li C; Yu H; Wei X; Liu X; Bao W; Shi Y; Sun X; Khamrakulov M; Yang C; Liu H
    J Med Chem; 2021 Jul; 64(13):9217-9237. PubMed ID: 34181850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death.
    Yao Y; Yuan M; Shi M; Li W; Sha Y; Zhang Y; Yuan C; Luo J; Li Z; Liao C; Xu K; Niu M
    Blood Adv; 2024 Aug; 8(15):4003-4016. PubMed ID: 38820414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
    Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
    Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing.
    Wittner L; Wagener L; Wiese JJ; Stolzer I; Krug SM; Naschberger E; Jackstadt R; Beyaert R; Atreya R; Kühl AA; Sturm G; Gonzalez-Acera M; Patankar JV; Becker C; Siegmund B; Trajanoski Z; Winner B; Neurath MF; Schumann M; Günther C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity.
    Unterreiner A; Touil R; Anastasi D; Dubois N; Niwa S; Calzascia T; Bornancin F
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30663686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma dissemination.
    Juilland M; Alouche N; Ubezzi I; Gonzalez M; Rashid HO; Scarpellino L; Erdmann T; Grau M; Lenz G; Luther SA; Thome M
    Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2301155120. PubMed ID: 38109544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful clinical treatment and functional immunological normalization of human MALT1 deficiency following hematopoietic stem cell transplantation.
    Rozmus J; McDonald R; Fung SY; Del Bel KL; Roden J; Senger C; Schultz KR; McKinnon ML; Davis J; Turvey SE
    Clin Immunol; 2016 Jul; 168():1-5. PubMed ID: 27109639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.
    Sun L; Deng L; Ea CK; Xia ZP; Chen ZJ
    Mol Cell; 2004 May; 14(3):289-301. PubMed ID: 15125833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.
    McAuley JR; Bailey KM; Ekambaram P; Klei LR; Kang H; Hu D; Freeman TJ; Concel VJ; Hubel NE; Lee JL; Klei HB; Cheng J; Sekar P; Bridwell RE; Covic L; Lucas PC; McAllister-Lucas LM
    Oncogene; 2019 Dec; 38(49):7384-7398. PubMed ID: 31420608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice.
    Baens M; Stirparo R; Lampi Y; Verbeke D; Vandepoel R; Cools J; Marynen P; de Bock CE; Bornschein S
    Eur J Immunol; 2018 Oct; 48(10):1728-1738. PubMed ID: 30025160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
    Afonina IS; Elton L; Carpentier I; Beyaert R
    FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.
    Staal J; Driege Y; Bekaert T; Demeyer A; Muyllaert D; Van Damme P; Gevaert K; Beyaert R
    EMBO J; 2011 May; 30(9):1742-52. PubMed ID: 21448133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential requirement for Malt1 in T and B cell antigen receptor signaling.
    Ruland J; Duncan GS; Wakeham A; Mak TW
    Immunity; 2003 Nov; 19(5):749-58. PubMed ID: 14614861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
    Juilland M; Thome M
    Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protease activity of the paracaspase MALT1 is controlled by monoubiquitination.
    Pelzer C; Cabalzar K; Wolf A; Gonzalez M; Lenz G; Thome M
    Nat Immunol; 2013 Apr; 14(4):337-45. PubMed ID: 23416615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A patent review of MALT1 inhibitors (2013-present).
    Hamp I; O'Neill TJ; Plettenburg O; Krappmann D
    Expert Opin Ther Pat; 2021 Dec; 31(12):1079-1096. PubMed ID: 34214002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.